Clinical Trial Update: RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma [Phase 3]

View source ↗

Summary

Phase 3 RETIC trial evaluating reversal of trauma-induced coagulopathy with coagulation factor concentrates versus fresh frozen plasma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Trauma

Drugs mentioned

• Coagulation Factor Concentrates (coagulation factor concentrates)
• Fresh Frozen Plasma (fresh frozen plasma)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Major Trauma | Phase 3 | Status: TERMINATED